These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38928008)

  • 1. Mitochondrial One-Carbon Metabolism and Alzheimer's Disease.
    Yu Y; Martins LM
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions.
    Yao J; Rettberg JR; Klosinski LP; Cadenas E; Brinton RD
    Mol Aspects Med; 2011 Aug; 32(4-6):247-57. PubMed ID: 22024249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
    Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
    EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mitochondrial bottleneck hypothesis of Alzheimer's disease.
    Davis JN; Hunnicutt EJ; Chisholm JC
    Mol Med Today; 1995 Aug; 1(5):240-7. PubMed ID: 17607886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities.
    Perez Ortiz JM; Swerdlow RH
    Br J Pharmacol; 2019 Sep; 176(18):3489-3507. PubMed ID: 30675901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges.
    Han Y; Liu D; Cheng Y; Ji Q; Liu M; Zhang B; Zhou S
    Redox Biol; 2023 Jul; 63():102734. PubMed ID: 37159984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial alterations in Alzheimer's disease.
    Baloyannis SJ
    J Alzheimers Dis; 2006 Jul; 9(2):119-26. PubMed ID: 16873959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective Mitochondrial Pyruvate Flux Affects Cell Bioenergetics in Alzheimer's Disease-Related Models.
    Rossi A; Rigotto G; Valente G; Giorgio V; Basso E; Filadi R; Pizzo P
    Cell Rep; 2020 Feb; 30(7):2332-2348.e10. PubMed ID: 32075767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Mitochondrial Function as a Therapeutic Strategy for Neurodegenerative Diseases.
    Trushina E; Nguyen TKO; Trushin S
    J Prev Alzheimers Dis; 2023; 10(4):675-685. PubMed ID: 37874088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.
    Moreira PI; Santos MS; Seiça R; Oliveira CR
    J Neurol Sci; 2007 Jun; 257(1-2):206-14. PubMed ID: 17316694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Bioenergetics in Neurodegeneration.
    Strope TA; Birky CJ; Wilkins HM
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Disorders in Alzheimer's Disease.
    Sukhorukov VS; Mudzhiri NM; Voronkova AS; Baranich TI; Glinkina VV; Illarioshkin SN
    Biochemistry (Mosc); 2021 Jun; 86(6):667-679. PubMed ID: 34225590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal Glucose Metabolism in Alzheimer's Disease: Relation to Autophagy/Mitophagy and Therapeutic Approaches.
    Banerjee K; Munshi S; Frank DE; Gibson GE
    Neurochem Res; 2015 Dec; 40(12):2557-69. PubMed ID: 26077923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTCD1 Is Required for Mitochondrial Oxidative-Phosphorylation: Possible Genetic Association with Alzheimer's Disease.
    Fleck D; Phu L; Verschueren E; Hinkle T; Reichelt M; Bhangale T; Haley B; Wang Y; Graham R; Kirkpatrick DS; Sheng M; Bingol B
    J Neurosci; 2019 Jun; 39(24):4636-4656. PubMed ID: 30948477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Link between the unfolded protein response and dysregulation of mitochondrial bioenergetics in Alzheimer's disease.
    Poirier Y; Grimm A; Schmitt K; Eckert A
    Cell Mol Life Sci; 2019 Apr; 76(7):1419-1431. PubMed ID: 30683981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Mitochondrial Dysfunction in the Pathology of Amyloid-β.
    Huang Z; Yan Q; Wang Y; Zou Q; Li J; Liu Z; Cai Z
    J Alzheimers Dis; 2020; 78(2):505-514. PubMed ID: 33044180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-onset Alzheimer's disease is associated with inherent changes in bioenergetics profiles.
    Sonntag KC; Ryu WI; Amirault KM; Healy RA; Siegel AJ; McPhie DL; Forester B; Cohen BM
    Sci Rep; 2017 Oct; 7(1):14038. PubMed ID: 29070876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid precursor protein-mediated mitochondrial regulation and Alzheimer's disease.
    Lopez Sanchez MIG; van Wijngaarden P; Trounce IA
    Br J Pharmacol; 2019 Sep; 176(18):3464-3474. PubMed ID: 30471088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting mitochondrial bioenergetics for Alzheimer's prevention and treatment.
    Yao J; Brinton RD
    Curr Pharm Des; 2011; 17(31):3474-9. PubMed ID: 21902662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction and cellular metabolic deficiency in Alzheimer's disease.
    Gu XM; Huang HC; Jiang ZF
    Neurosci Bull; 2012 Oct; 28(5):631-40. PubMed ID: 22968595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.